FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Tolentino

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Macaca fascicularis

Procedures

Fluorescein Angiography

Anatomy

Physiology

Capillary Permeability

Co-author Network

Publications

TOP 3
Peter A Campochiaro; David M Brown; Andrew Pearson; Thomas Ciulla; David Boyer; Frank G Holz; Michael J Tolentino; Amod Gupta; Lilianne Duarte; Steven Madreperla; John Gonder; Barry Kapik; Kathleen Billman; Frances E Kane
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Mark P Hatton; Heidi D Remulla; Michael J Tolentino; Peter A D Rubin
Clinical applications of color Doppler imaging in the management of orbital lesions.
Michael J Tolentino; Deeba Husain; P Theodosiadis; Evangelos S Gragoudas; Edward Connolly; J Kahn; J Cleland; Anthony P Adamis; A Cuthbertson; Joan W Miller
Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Tolentino (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Peter A Campochiaro; David M Brown; Andrew Pearson; Thomas Ciulla; David Boyer; Frank G Holz; Michael J Tolentino; Amod Gupta; Lilianne Duarte; Steven Madreperla; John Gonder; Barry Kapik; Kathleen Billman; Frances E Kane
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Ophthalmology 2011;118(4):626-635.e2.
2002: Mark P Hatton; Heidi D Remulla; Michael J Tolentino; Peter A D Rubin
Clinical applications of color Doppler imaging in the management of orbital lesions.
Ophthalmic plastic and reconstructive surgery 2002;18(6):462-5.
2000: Michael J Tolentino; Deeba Husain; P Theodosiadis; Evangelos S Gragoudas; Edward Connolly; J Kahn; J Cleland; Anthony P Adamis; A Cuthbertson; Joan W Miller
Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.
Archives of ophthalmology 2000;118(1):78-84.
1999: N Hayashi; G Borodic; J W Karesh; Michael J Tolentino; Heidi D Remulla; R A Van Wesep; H E Grossniklaus; Frederick A Jakobiec; W Richard Green
Giant cell angiofibroma of the orbit and eyelid.
Ophthalmology 1999;106(6):1223-9.
1998: Michael J Tolentino; Anthony P Adamis
Angiogenic factors in the development of diabetic iris neovascularization and retinopathy.
International ophthalmology clinics 1998;38(1):77-94.
1997: Constantin J Pournaras; Joan W Miller; Evangelos S Gragoudas; Deeba Husain; Jean-Luc Munoz; Michael J Tolentino; M Kuroki; Anthony P Adamis
Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina.
Archives of ophthalmology 1997;115(12):1553-8.
1996: T E Nicaeus; Michael J Tolentino; Anthony P Adamis; Peter A D Rubin
Sucralfate and basic fibroblast growth factor promote endothelial cell proliferation around porous alloplastic implants in vitro.
Ophthalmic plastic and reconstructive surgery 1996;12(4):235-9.
1996: Michael J Tolentino; Joan W Miller; Evangelos S Gragoudas; Frederick A Jakobiec; Evelyn Flynn; K Chatzistefanou; N Ferrara; Anthony P Adamis
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
Ophthalmology 1996;103(11):1820-8.
1996: M Kuroki; E E Voest; S Amano; L V Beerepoot; S Takashima; Michael J Tolentino; R Y Kim; Richard M Rohan; K A Colby; K T Yeo; Anthony P Adamis
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
The Journal of clinical investigation 1996;98(7):1667-75.
1996: Michael J Tolentino; Joan W Miller; Evangelos S Gragoudas; K Chatzistefanou; N Ferrara; Anthony P Adamis
Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.
Archives of ophthalmology 1996;114(8):964-70.
1996: D T Shima; A Gougos; Joan W Miller; Michael J Tolentino; G Robinson; Anthony P Adamis; P A D'Amore
Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.
Investigative ophthalmology & visual science 1996;37(7):1334-40.
1996: Anthony P Adamis; D T Shima; Michael J Tolentino; Evangelos S Gragoudas; N Ferrara; Judah Folkman; P A D'Amore; Joan W Miller
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.
Archives of ophthalmology 1996;114(1):66-71.
1995: C Chen; S Parangi; Michael J Tolentino; Judah Folkman
A strategy to discover circulating angiogenesis inhibitors generated by human tumors.
Cancer research 1995;55(19):4230-3.
1994: Michael J Tolentino; S Miller; Alexander R Gaudio; Michael A Sandberg
Visual field deficits in early age-related macular degeneration.
Vision research 1994;34(3):409-13.
1993: Michael A Sandberg; Michael J Tolentino; S Miller; Eliot L Berson; Alexander R Gaudio
Hyperopia and neovascularization in age-related macular degeneration.
Ophthalmology 1993;100(7):1009-13.